Related Experiment Videos
[Acquired renal cystic disease]
K Kawamura1, R Ikeda, K Suzuki
1Department of Urology, Kanazawa Medical University.
Hinyokika Kiyo. Acta Urologica Japonica
|December 7, 2000
Summary
Acquired cystic disease of the kidney (ACDK) is common in hemodialysis patients, increasing renal cell carcinoma (RCC) risk. Early detection through regular screening like CT scans is crucial for managing this condition.
Area of Science:
- Nephrology
- Oncology
- Radiology
Context:
- Acquired cystic disease of the kidney (ACDK) is frequently observed in patients undergoing long-term hemodialysis.
- The incidence of ACDK rises significantly with dialysis duration, particularly in male patients.
- ACDK can occur even before patients begin hemodialysis.
Purpose:
- To highlight the increased incidence of renal cell carcinoma (RCC) in patients with ACDK.
- To emphasize the necessity of early detection and screening for RCC in ACDK patients.
- To discuss the management and potential risks associated with RCC in the context of ACDK.
Summary:
- ACDK affects 40-50% of hemodialysis patients, with incidence exceeding 90% after 5-10 years.
- Patients with ACDK have a 5-19% increased risk of developing renal cell carcinoma (RCC), which may be asymptomatic.
- Regular screening via ultrasound or CT scans is recommended for early RCC detection in ACDK patients, with nephrectomy indicated for suspected or confirmed kidney cancer.
Impact:
- Early detection of renal cell carcinoma (RCC) in acquired cystic disease of the kidney (ACDK) patients can improve outcomes.
- Understanding the link between ACDK and RCC aids in developing targeted monitoring strategies.
- This research underscores the importance of vigilant radiologic monitoring for end-stage renal disease patients with ACDK.